Helmy Eltoukhy

New Capabilities

Leading commercial rollout of Guardant360 Liquid CDx

For most patients with advanced cancer, picking the right targeted drug still starts with a tissue biopsy. On May 20, the FDA approved a blood test that reads 100 times more of the tumor's DNA than the previous version.

Updated May 20